Literature DB >> 1354992

Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug.

N Solowij1, W Hall, N Lee.   

Abstract

'Ecstasy' (3,4-methylenedioxymethamphetamine or MDMA) is a recreational drug that is gaining popularity world wide. There is a paucity of research regarding the ways in which Ecstasy is used and the nature of its effects. A 'snowball' peer network technique was used to recruit 100 users who completed anonymous questionnaires. The research revealed that Ecstasy is primarily used by infrequent recreational drug users for 'fun' at dance parties and social gatherings. The primary reported effects of Ecstasy were a 'positive mood state' and feelings of intimacy and closeness to others. The secondary effects of Ecstasy were the stimulant effects of energy and activation, and the psychedelic effects of insight and perceptual and sensual enhancement. Ecstasy was reported to share the properties of both amphetamines and hallucinogens in the nature of its side effects and residual effects which were no more severe than those of the latter two classes of drug. It appeared Ecstasy was not conductive to regular and frequent use, because tolerance was reported to develop to the positive effects of Ecstasy, while negative effects increased with use. Although few problems associated with the recreational use of Ecstasy have surfaced to date, animal research has shown it to be neurotoxic to serotonergic nerve terminals. Caution must be observed until further research can determine the level of hazard in humans.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1354992     DOI: 10.1111/j.1360-0443.1992.tb02003.x

Source DB:  PubMed          Journal:  Br J Addict        ISSN: 0952-0481


  54 in total

Review 1.  Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse.

Authors:  Antonio Verdejo-García; Francisca López-Torrecillas; Carmen Orozco Giménez; Miguel Pérez-García
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

2.  Effects of ecstasy/polydrug use on memory for associative information.

Authors:  Denis T Gallagher; John E Fisk; Catharine Montgomery; Jeannie Judge; Sarita J Robinson; Paul J Taylor
Journal:  Psychopharmacology (Berl)       Date:  2012-08       Impact factor: 4.530

3.  Neuropsychological effects associated with recreational cocaine use.

Authors:  Kirstie Soar; Colette Mason; Anita Potton; Lynne Dawkins
Journal:  Psychopharmacology (Berl)       Date:  2012-02-29       Impact factor: 4.530

4.  Reasoning deficits in ecstasy (MDMA) polydrug users.

Authors:  John E Fisk; Catharine Montgomery; Michelle Wareing; Philip N Murphy
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

5.  The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory.

Authors:  Catharine Montgomery; John E Fisk; Russell Newcombe; Phillip N Murphy
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

6.  Ecstasy and gateway drugs: initiating the use of ecstasy and other drugs.

Authors:  Lesley W Reid; Kirk W Elifson; Claire E Sterk
Journal:  Ann Epidemiol       Date:  2006-11-29       Impact factor: 3.797

7.  Understanding recreational ecstasy use in the United States: a qualitative inquiry.

Authors:  Masuma Bahora; Claire E Sterk; Kirk W Elifson
Journal:  Int J Drug Policy       Date:  2008-02-20

8.  Reinstatement of MDMA (ecstasy) seeking by exposure to discrete drug-conditioned cues.

Authors:  Kevin T Ball; Kelly M Walsh; George V Rebec
Journal:  Pharmacol Biochem Behav       Date:  2007-06-02       Impact factor: 3.533

9.  Poly-Drug Use among Ecstasy Users: Separate, Synergistic, and Indiscriminate Patterns.

Authors:  M Boeri; C Sterk; M Bahora; K Elifson
Journal:  J Drug Issues       Date:  2008-04

10.  Chronic MDMA (ecstasy) use, cognition and mood.

Authors:  K McCardle; S Luebbers; J D Carter; R J Croft; C Stough
Journal:  Psychopharmacology (Berl)       Date:  2004-04-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.